Africa HepatoPancreatoBiliary Cancer Consortium
2026 AHPBCC Annual Conference
August 12–16, 2026 · Abuja, Nigeria
Collaborating to Improve HPB Cancer Control in Africa: Prevention, Treatment, Research, and Survivorship
About Us
In 2020, the Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC) was organized to harness resources and expertise across the African Continent, the United States, and Europe to investigate the influences of lifestyle, environment, viral and host biological factors on the development of HPB cancers. Today the Consortium has more than 200 clinicians and research investigators who inform new strategies for risk prevention, early detection, and improved survival of patients with these cancers.
Our Mission
Develop and support collaborations between member groups
Identify factors that influence the epidemiology, etiology, pathobiology, and prognosis of liver, biliary tract and pancreatic cancers
Objectives
Expand knowledge of the epidemiology, etiology, pathobiology and prognosis of liver, biliary tract and pancreatic cancers through:
Foster Collaborations
between clinicians and researchers in different countries;
Providing a forum
Promote and support
high-quality patient and population-based basic and translational science research throughout Africa;
Supporting
Supporting the development and mentorship of early career researchers and clinicians.

